病毒疫苗-话题@MedSci

#病毒疫苗#

218篇内容 | 3209人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2083329, encodeId=fa992083329a5, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=科兴生物新冠病毒疫苗初步显示安全有效！三期临床试验将在中国和巴西进行, objectType=article, longId=196013, objectId=c3f3196013e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3f3196013e0, replyNumber=0, likeNumber=87, createdTime=2021-01-02, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3f3196013e0, moduleTitle=科兴生物新冠病毒疫苗初步显示安全有效！三期临床试验将在中国和巴西进行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3f3196013e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083330, encodeId=0ad5208333061, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=欧盟批准强生的埃博拉病毒疫苗方案, objectType=article, longId=196916, objectId=7b3f196916dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b3f196916dd, replyNumber=0, likeNumber=80, createdTime=2021-06-10, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b3f196916dd, moduleTitle=欧盟批准强生的埃博拉病毒疫苗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b3f196916dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083320, encodeId=241f208332002, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=以色列称研制新冠病毒疫苗取得重大进展，正准备进行动物实验, objectType=article, longId=191320, objectId=72c91913205a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72c91913205a, replyNumber=0, likeNumber=85, createdTime=2020-09-26, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72c91913205a, moduleTitle=以色列称研制新冠病毒疫苗取得重大进展，正准备进行动物实验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72c91913205a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083339, encodeId=9e9120833390c, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=BMC Infect Dis：轮状病毒疫苗可减少严重轮状病毒感染的发生率, objectType=article, longId=203121, objectId=2d93203121ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d93203121ab, replyNumber=0, likeNumber=71, createdTime=2021-04-17, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d93203121ab, moduleTitle=BMC Infect Dis：轮状病毒疫苗可减少严重轮状病毒感染的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d93203121ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083332, encodeId=cd79208333298, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=NEJM：孕期接种呼吸道合胞病毒疫苗可降低新生儿RSV感染风险, objectType=article, longId=198415, objectId=22bd19841545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22bd19841545, replyNumber=0, likeNumber=70, createdTime=2021-02-10, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22bd19841545, moduleTitle=NEJM：孕期接种呼吸道合胞病毒疫苗可降低新生儿RSV感染风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22bd19841545)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083316, encodeId=61ef20833166f, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=ERVEBO（扎伊尔型埃博拉病毒疫苗）已在欧盟、美国、非洲等地上市, objectType=article, longId=188193, objectId=a83d18819359, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a83d18819359, replyNumber=0, likeNumber=52, createdTime=2020-07-29, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a83d18819359, moduleTitle=ERVEBO（扎伊尔型埃博拉病毒疫苗）已在欧盟、美国、非洲等地上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a83d18819359)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083328, encodeId=9232208332825, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=张伯礼：加快新冠病毒疫苗III期临床试验, objectType=article, longId=194542, objectId=0f3a194542ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f3a194542ed, replyNumber=0, likeNumber=0, createdTime=2020-09-07, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f3a194542ed, moduleTitle=张伯礼：加快新冠病毒疫苗III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f3a194542ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083343, encodeId=aee0208334392, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=特大喜讯！中国新冠病毒疫苗获批上市，全民免费！, objectType=article, longId=205095, objectId=ec1320509530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec1320509530, replyNumber=0, likeNumber=69, createdTime=2021-10-01, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec1320509530, moduleTitle=特大喜讯！中国新冠病毒疫苗获批上市，全民免费！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec1320509530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083340, encodeId=642f208334037, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=NEJM：印度轮状病毒疫苗接种计划与肠套叠风险研究, objectType=article, longId=203323, objectId=a783203323bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a783203323bc, replyNumber=0, likeNumber=76, createdTime=2021-10-25, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a783203323bc, moduleTitle=NEJM：印度轮状病毒疫苗接种计划与肠套叠风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a783203323bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083337, encodeId=7352208333ee2, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=阿斯利康公司完整版新冠病毒疫苗临床试验设计方案（免积分下载）, objectType=article, longId=200996, objectId=c0942009961d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0942009961d, replyNumber=0, likeNumber=95, createdTime=2021-01-25, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0942009961d, moduleTitle=阿斯利康公司完整版新冠病毒疫苗临床试验设计方案（免积分下载）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0942009961d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083331, encodeId=145d20833317e, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=Nat Med：埃博拉病毒疫苗rVSV-ZEBOV的多克隆和趋向性抗体反应, objectType=article, longId=198085, objectId=f3a11980859a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a11980859a, replyNumber=0, likeNumber=81, createdTime=2021-01-15, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a11980859a, moduleTitle=Nat Med：埃博拉病毒疫苗rVSV-ZEBOV的多克隆和趋向性抗体反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3a11980859a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083341, encodeId=d6512083341f5, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=美国新冠病毒疫苗接种计划公布：明年4月前全国免费接种完毕，实现群体免疫, objectType=article, longId=203552, objectId=c74a203552ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c74a203552ee, replyNumber=0, likeNumber=66, createdTime=2021-07-15, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c74a203552ee, moduleTitle=美国新冠病毒疫苗接种计划公布：明年4月前全国免费接种完毕，实现群体免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c74a203552ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083335, encodeId=ab002083335a1, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=NEJM：新冠病毒疫苗NVX-CoV2373的1-2期临床试验结果, objectType=article, longId=200243, objectId=97ee20024318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ee20024318, replyNumber=0, likeNumber=65, createdTime=2021-08-15, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ee20024318, moduleTitle=NEJM：新冠病毒疫苗NVX-CoV2373的1-2期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ee20024318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083334, encodeId=90ef208333430, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=8月28日全球新冠肺炎（COVID-19）疫情简报，确诊超2460万，美国制裁俄新冠病毒疫苗研发机构, objectType=article, longId=199997, objectId=e27419999e87, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27419999e87, replyNumber=0, likeNumber=72, createdTime=2021-05-10, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27419999e87, moduleTitle=8月28日全球新冠肺炎（COVID-19）疫情简报，确诊超2460万，美国制裁俄新冠病毒疫苗研发机构, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27419999e87)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083336, encodeId=f8a52083336f9, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=Nature：研究人员强调俄罗斯冠状病毒疫苗试验结果存“可疑”数据！, objectType=article, longId=200731, objectId=f413200e31df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f413200e31df, replyNumber=0, likeNumber=35, createdTime=2020-11-14, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f413200e31df, moduleTitle=Nature：研究人员强调俄罗斯冠状病毒疫苗试验结果存“可疑”数据！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f413200e31df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083317, encodeId=cbb9208331e73, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=强生用埃博拉平台开发新冠病毒疫苗, objectType=article, longId=188586, objectId=d1d818858686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d818858686, replyNumber=0, likeNumber=59, createdTime=2020-09-01, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d818858686, moduleTitle=强生用埃博拉平台开发新冠病毒疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d818858686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083324, encodeId=104d208332453, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=科普：ADE效应与新冠病毒疫苗的研发, objectType=article, longId=192058, objectId=f17119205820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f17119205820, replyNumber=0, likeNumber=68, createdTime=2020-07-17, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f17119205820, moduleTitle=科普：ADE效应与新冠病毒疫苗的研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f17119205820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083311, encodeId=fd3e2083311cc, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=国产重组人乳头瘤病毒疫苗“馨可宁”获批上市, objectType=article, longId=185540, objectId=3465185540f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3465185540f6, replyNumber=0, likeNumber=58, createdTime=2020-09-17, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3465185540f6, moduleTitle=国产重组人乳头瘤病毒疫苗“馨可宁”获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3465185540f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083318, encodeId=6320208331867, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=新型冠状病毒疫苗：会很快来吗？, objectType=article, longId=189995, objectId=bf6318999527, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf6318999527, replyNumber=0, likeNumber=0, createdTime=2020-05-10, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf6318999527, moduleTitle=新型冠状病毒疫苗：会很快来吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf6318999527)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2083314, encodeId=bcc8208331405, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, objectTitle=在CEPI的支持下，全球科学家竞相开发新型冠状病毒疫苗, objectType=article, longId=187837, objectId=b2ed18e83764, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2ed18e83764, replyNumber=0, likeNumber=77, createdTime=2020-04-15, rootId=0, userName=huagfeg, userId=1dbc2500219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2ed18e83764, moduleTitle=在CEPI的支持下，全球科学家竞相开发新型冠状病毒疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2ed18e83764)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

病毒疫苗

2020-05-29

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

科兴生物新冠病毒疫苗初步显示安全有效！三期临床试验将在中国和巴西进行

2021-01-02

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

欧盟批准强生的埃博拉病毒疫苗方案

2021-06-10

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

以色列称研制新冠病毒疫苗取得重大进展，正准备进行动物实验

2020-09-26

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

BMC Infect Dis：轮状病毒疫苗可减少严重轮状病毒感染的发生率

2021-04-17

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

NEJM：孕期接种呼吸道合胞病毒疫苗可降低新生儿RSV感染风险

2021-02-10

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

ERVEBO（扎伊尔型埃博拉病毒疫苗）已在欧盟、美国、非洲等地上市

2020-07-29

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

张伯礼：加快新冠病毒疫苗III期临床试验

2020-09-07

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

特大喜讯！中国新冠病毒疫苗获批上市，全民免费！

2021-10-01

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

NEJM：印度轮状病毒疫苗接种计划与肠套叠风险研究

2021-10-25

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

阿斯利康公司完整版新冠病毒疫苗临床试验设计方案（免积分下载）

2021-01-25

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

Nat Med：埃博拉病毒疫苗rVSV-ZEBOV的多克隆和趋向性抗体反应

2021-01-15

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

美国新冠病毒疫苗接种计划公布：明年4月前全国免费接种完毕，实现群体免疫

2021-07-15

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

NEJM：新冠病毒疫苗NVX-CoV2373的1-2期临床试验结果

2021-08-15

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

8月28日全球新冠肺炎（COVID-19）疫情简报，确诊超2460万，美国制裁俄新冠病毒疫苗研发机构

2021-05-10

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

Nature：研究人员强调俄罗斯冠状病毒疫苗试验结果存“可疑”数据！

2020-11-14

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

强生用埃博拉平台开发新冠病毒疫苗

2020-09-01

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

科普：ADE效应与新冠病毒疫苗的研发

2020-07-17

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

国产重组人乳头瘤病毒疫苗“馨可宁”获批上市

2020-09-17

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

新型冠状病毒疫苗：会很快来吗？

2020-05-10

huagfeg (审核中...)

前往app查看评论内容

#病毒疫苗#

在CEPI的支持下，全球科学家竞相开发新型冠状病毒疫苗

2020-04-15

科室
- - 订阅+
  - 更多科室
工具
服务